CoChat

Developmental malformations in Huntington disease: neuropathologic evidence of focal neuronal migration defects in a subset of adult brains

Hickman, R. A., Faust, P. L., Rosenblum, M. K., Marder, K., Mehler, M. F., Vonsattel, J. P. · 2021 · Acta Neuropathologica
Cited by 42

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Neuropathologic hallmarks of Huntington Disease (HD) include the progressive neurodegeneration of the striatum and the presence of Huntingtin (HTT) aggregates that result from abnormal polyQ expansion of the HTT gene. Whether the pathogenic trinucleotide repeat expansion of the HTT gene causes neurodevelopmental abnormalities has garnered attention in both murine and human studies; however, documentation of discrete malformations in autopsy brains of HD individuals has yet to be described. We retrospectively searched the New York Brain Bank (discovery cohort) and an independent cohort (validation cohort) to determine whether developmental malformations are more frequently detected in HD versus non-HD brains and to document their neuropathologic features. One-hundred and thirty HD and 1600 non-HD whole brains were included in the discovery cohort and 720 HD and 1989 non-HD half brains were assessed in the validation cohort. Cases with developmental malformations were found at 6.4–8.2 times greater frequency in HD than in non-HD brains (discovery cohort: OR 8.68, 95% CI 3.48–21.63, P=4.8 × 10-5; validation cohort: OR 6.50, 95% CI 1.83–23.17, P=0.0050). Periventricular nodular heterotopias (PNH) were the most frequent malformations and contained HTT and p62 aggregates analogous to the cortex, whereas cortical malformations with immature neuronal populations did not harbor such inclusions. HD individuals with malformations had heterozygous HTT CAG expansions between 40 and 52 repeats, were more frequently women, and all were asymmetric and focal, aside from one midline hypothalamic hamartoma. Using two independent brain bank cohorts, this large neuropathologic series demonstrates an increased occurrence of developmental malformations in HD brains. Since pathogenic HTT gene expansion is associated with genomic instability, one possible explanation is that neuronal precursors are more susceptible to somatic mutation of genes involved in cortical migration. Our findings further support emerging evidence that pathogenic trinucleotide repeat expansions of the HTT gene may impact neurodevelopment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-021-02269-4

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 54

  1. (2019) CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset. Cell 178:887–900.e814. https://doi.org/10.1016/j.cell.2019.06.036 · DOI · Paper page
  2. Arteaga-Bracho EE, Gulinello M, Winchester ML, Pichamoorthy N, Petronglo JR, Zambrano AD, Inocencio J, De Jesus CD, Louie JO, Gokhan S et al (2016) Postnatal and adult consequences of loss of huntingtin during development: implications for Huntington’s disease. Neurobiol Dis 96:144–155. https://doi.org/10.1016/j.nbd.2016.09.006 · DOI · Paper page
  3. Auerbach W, Hurlbert MS, Hilditch-Maguire P, Wadghiri YZ, Wheeler VC, Cohen SI, Joyner AL, MacDonald ME, Turnbull DH (2001) The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of huntingtin. Hum Mol Genet 10:2515–2523. https://doi.org/10.1093/hmg/10.22.2515 · DOI · Paper page
  4. Bae T, Tomasini L, Mariani J, Zhou B, Roychowdhury T, Franjic D, Pletikos M, Pattni R, Chen B-J, Venturini E et al (2018) Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis. Science (New York, NY) 359:550–555. https://doi.org/10.1126/science.aan8690 · DOI · Paper page
  5. Barkovich A, Kjos B (1992) Gray matter heterotopias: MR characteristics and correlation with developmental and neurologic manifestations. Radiology 182:493–499 · DOI · Paper page
  6. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB (2012) A developmental and genetic classification for malformations of cortical development: update 2012. Brain 135:1348–1369 · DOI · Paper page
  7. Bhide PG, Day M, Sapp E, Schwarz C, Sheth A, Kim J, Young AB, Penney J, Golden J, Aronin N et al (1996) Expression of normal and mutant huntingtin in the developing brain. J Neurosci 16:5523–5535. https://doi.org/10.1523/jneurosci.16-17-05523.1996 · DOI · Paper page
  8. Bieniek KF, Dickson DW (2015) Concurrent neurodegenerative pathologies in periventricular nodular heterotopia. Acta Neuropathol 130:895–897. https://doi.org/10.1007/s00401-015-1490-4 · DOI
  9. Blümcke I, Giencke K, Wardelmann E, Beyenburg S, Kral T, Sarioglu N, Pietsch T, Wolf HK, Schramm J, Elger CE (1999) The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies. Acta Neuropathol 97:481–490 · DOI · Paper page
  10. Coons SW, Rekate HL, Prenger EC, Wang N, Drees C, Ng Y-t, Chung SS, Kerrigan JF (2007) The histopathology of hypothalamic hamartomas: study of 57 cases. J Neuropathol Exp Neurol 66:131–141 · DOI
  11. Croce KR, Yamamoto A (2019) A role for autophagy in Huntington’s disease. Neurobiol Dis 122:16–22. https://doi.org/10.1016/j.nbd.2018.08.010 · DOI · Paper page
  12. 17D’Gama AM, Walsh CA (2018) Somatic mosaicism and neurodevelopmental disease. Nat Neurosci 21:1504–1514 · DOI · Paper page
  13. Dehay B, Weber C, Trottier Y, Bertolotti A (2007) Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicity. Biotechnol J 2:559–564. https://doi.org/10.1002/biot.200600249 · DOI
  14. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC, Group P-HIotHS (2007) Psychiatric symptoms in Huntington’s disease before diagnosis: the predict-HD study. Biol Psychiatry 62:1341–1346 · DOI · Paper page
  15. Ferland RJ, Batiz LF, Neal J, Lian G, Bundock E, Lu J, Hsiao Y-C, Diamond R, Mei D, Banham AH et al (2009) Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Human Mol Genet 18:497–516. https://doi.org/10.1093/hmg/ddn377 · DOI · Paper page
  16. Ferlazzo ML, Sonzogni L, Granzotto A, Bodgi L, Lartin O, Devic C, Vogin G, Pereira S, Foray N (2014) Mutations of the Huntington’s disease protein impact on the ATM-dependent signaling and repair pathways of the radiation-induced DNA double-strand breaks: corrective effect of statins and bisphosphonates. Mol Neurobiol 49:1200–1211. https://doi.org/10.1007/s12035-013-8591-7 · DOI
  17. Fox JW, Lamperti ED, Ekşioğlu YZ, Hong SE, Feng Y, Graham DA, Scheffer IE, Dobyns WB, Hirsch BA, Radtke RA et al (1998) Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 21:1315–1325. https://doi.org/10.1016/s0896-6273(00)80651-0 · DOI · Paper page
  18. Gao R, Chakraborty A, Geater C, Pradhan S, Gordon KL, Snowden J, Yuan S, Dickey AS, Choudhary S, Ashizawa T et al (2019) Mutant huntingtin impairs PNKP and ATXN3, disrupting DNA repair and transcription. Elife. https://doi.org/10.7554/eLife.42988 · DOI · Paper page
  19. Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, Charrin BC, Dietrich P, Volvert ML, Guillemot F, Dragatsis I et al (2010) Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67:392–406. https://doi.org/10.1016/j.neuron.2010.06.027 · DOI · Paper page
  20. Gómez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Vonsattel JP (2001) Quantitative neuropathological changes in presymptomatic Huntington’s disease. Ann Neurol 49:29–34 · doi:10.1002/1531-8249(200101)49:1<29::aid-ana7>3.0.co;2-b · Paper page
  21. Hickman RA, Flowers XE, Wisniewski T (2020) Primary age-related tauopathy (PART): addressing the spectrum of neuronal tauopathic changes in the aging brain. Curr Neurol Neurosci Rep 20:1–11 · DOI
  22. Huse JT, Edgar M, Halliday J, Mikolaenko I, Lavi E, Rosenblum MK (2013) Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol 23:515–524 · DOI
  23. Joseph JT (1997) Periventricular heterotopias display cortical degenerative neuropathology. Neurology 49:884–887 · doi:10.1212/wnl.49.3.884
  24. Keller CE, Del Amaya MP, Cortes EP, Mancevska K, Vonsattel JPG (2008) Electronic tracking of human brain samples for research. Cell Tissue Banking 9:217–227 · DOI
  25. Kennedy L, Evans E, Chen CM, Craven L, Detloff PJ, Ennis M, Shelbourne PF (2003) Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet 12:3359–3367. https://doi.org/10.1093/hmg/ddg352 · DOI · Paper page
  26. Kennedy L, Shelbourne PF (2000) Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington’s disease? Hum Mol Genet 9:2539–2544. https://doi.org/10.1093/hmg/9.17.2539 · DOI · Paper page
  27. Lee JK, Mathews K, Schlaggar B, Perlmutter J, Paulsen JS, Epping E, Burmeister L, Nopoulos P (2012) Measures of growth in children at risk for Huntington disease. Neurology 79:668–674. https://doi.org/10.1212/WNL.0b013e3182648b65 · DOI · Paper page
  28. Lian G, Sheen VL (2015) Cytoskeletal proteins in cortical development and disease: actin associated proteins in periventricular heterotopia. Front Cell Neurosci. https://doi.org/10.3389/fncel.2015.00099 · DOI · Paper page
  29. MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983 · DOI · Paper page
  30. Maiuri T, Bowie LE, Truant R (2019) DNA repair signaling of huntingtin: the next link between late-onset neurodegenerative disease and oxidative DNA damage. DNA Cell Biol 38:1–6. https://doi.org/10.1089/dna.2018.4476 · DOI
  31. Maiuri T, Mocle AJ, Hung CL, Xia J, van Roon-Mom WM, Truant R (2017) Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. Hum Mol Genet 26:395–406. https://doi.org/10.1093/hmg/ddw395 · DOI · Paper page
  32. Marder K, Mehler MF (2012) Development and neurodegeneration: turning HD pathogenesis on its head. Neurology 79:621–622. https://doi.org/10.1212/WNL.0b013e3182648bfe · DOI
  33. Mehler MF, Petronglo JR, Arteaga-Bracho EE, Gulinello ME, Winchester ML, Pichamoorthy N, Young SK, DeJesus CD, Ishtiaq H, Gokhan S et al (2019) Loss-of-Huntingtin in medial and lateral ganglionic lineages differentially disrupts regional interneuron and projection neuron subtypes and promotes Huntington’s disease-associated behavioral, cellular, and pathological hallmarks. J Neurosci 39:1892–1909. https://doi.org/10.1523/jneurosci.2443-18.2018 · DOI
  34. Mouro Pinto R, Arning L, Giordano JV, Razghandi P, Andrew MA, Gillis T, Correia K, Mysore JS, Grote Urtubey D-M, Parwez CR (2020) Patterns of CAG repeat instability in the central nervous system and periphery in Huntington’s disease and in spinocerebellar ataxia type 1. Human Mol Genet 29:2551–2567 · DOI
  35. Nagano T, Yoneda T, Hatanaka Y, Kubota C, Murakami F, Sato M (2002) Filamin A-interacting protein (FILIP) regulates cortical cell migration out of the ventricular zone. Nat Cell Biol 4:495–501. https://doi.org/10.1038/ncb808 · DOI
  36. Nasir J, Floresco SB, O’Kusky JR, Diewert VM, Richman JM, Zeisler J, Borowski A, Marth JD, Phillips AG, Hayden MR (1995) Targeted disruption of the Huntington’s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811–823. https://doi.org/10.1016/0092-8674(95)90542-1 · DOI · Paper page
  37. Nopoulos P, Magnotta VA, Mikos A, Paulson H, Andreasen NC, Paulsen JS (2007) Morphology of the cerebral cortex in preclinical Huntington’s disease. Am J Psychiatry 164:1428–1434. https://doi.org/10.1176/appi.ajp.2007.06081266 · DOI
  38. Nopoulos PC, Aylward EH, Ross CA, Mills JA, Langbehn DR, Johnson HJ, Magnotta VA, Pierson RK, Beglinger LJ, Nance MA et al (2011) Smaller intracranial volume in prodromal Huntington’s disease: evidence for abnormal neurodevelopment. Brain 134:137–142. https://doi.org/10.1093/brain/awq280 · DOI · Paper page
  39. Oegema R, Barkovich AJ, Mancini GMS, Guerrini R, Dobyns WB (2019) Subcortical heterotopic gray matter brain malformations: Classification study of 107 individuals. Neurology. https://doi.org/10.1212/wnl.0000000000008200 · doi:10.1212/wnl.0000000000008200
  40. Paulsen JS, Nopoulos PC, Aylward E, Ross CA, Johnson H, Magnotta VA, Juhl A, Pierson RK, Mills J, Langbehn D (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull 82:201–207 · DOI · Paper page
  41. Pekmezci M, Stevers M, Phillips JJ, Van Ziffle J, Bastian BC, Tsankova NM, Kleinschmidt-DeMasters BK, Rosenblum MK, Tihan T, Perry A et al (2018) Multinodular and vacuolating neuronal tumor of the cerebrum is a clonal neoplasm defined by genetic alterations that activate the MAP kinase signaling pathway. Acta Neuropathol 135:485–488. https://doi.org/10.1007/s00401-018-1820-4 · doi:10.1007/s00401-018-1820-4
  42. Raymond A, Fish D, Sisodiya S, Alsanjari N, Stevens J, Shorvon S (1995) Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy: clinical, EEG and neuroimaging features in 100 adult patients. Brain 118:629–660 · DOI · Paper page
  43. Saudou F, Humbert S (2016) The biology of huntingtin. Neuron 89:910–926 · DOI · Paper page
  44. Sheen VL, Dixon PH, Fox JW, Hong SE, Kinton L, Sisodiya SM, Duncan JS, Dubeau F, Scheffer IE, Schachter SC et al (2001) Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females. Hum Mol Genet 10:1775–1783. https://doi.org/10.1093/hmg/10.17.1775 · DOI · Paper page
  45. Sheen VL, Ganesh VS, Topcu M, Sebire G, Bodell A, Hill RS, Grant PE, Shugart YY, Imitola J, Khoury SJ et al (2004) Mutations in ARFGEF2 implicate vesicle trafficking in neural progenitor proliferation and migration in the human cerebral cortex. Nat Genet 36:69–76. https://doi.org/10.1038/ng1276 · DOI · Paper page
  46. Shelbourne PF, Keller-McGandy C, Bi WL, Yoon SR, Dubeau L, Veitch NJ, Vonsattel JP, Wexler NS, Arnheim N, Augood SJ (2007) Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Hum Mol Genet 16:1133–1142. https://doi.org/10.1093/hmg/ddm054 · DOI · Paper page
  47. Solomon AC, Stout JC, Johnson SA, Langbehn DR, Aylward EH, Brandt J, Ross CA, Beglinger L, Hayden MR, Kieburtz K (2007) Verbal episodic memory declines prior to diagnosis in Huntington’s disease. Neuropsychologia 45:1767–1776 · DOI · Paper page
  48. Thom M, Liu J, Bongaarts A, Reinten RJ, Paradiso B, Jäger HR, Reeves C, Somani A, An S, Marsdon D (2018) Multinodular and vacuolating neuronal tumors in epilepsy: dysplasia or neoplasia? Brain Pathol 28:155–171 · DOI
  49. van der Plas E, Langbehn DR, Conrad AL, Koscik TR, Tereshchenko A, Epping EA, Magnotta VA, Nopoulos PC (2019) Abnormal brain development in child and adolescent carriers of mutant huntingtin. Neurology 93:e1021–e1030. https://doi.org/10.1212/wnl.0000000000008066 · DOI
  50. Veeraval L, O’Leary CJ, Cooper HM (2020) Adherens junctions: guardians of cortical development. Front Cell Dev Biol 8:6–6. https://doi.org/10.3389/fcell.2020.00006 · DOI · Paper page
  51. Vonsattel JP, Del Amaya MP, Keller CE (2008) Twenty-first century brain banking. Processing brains for research: the Columbia University methods. Acta Neuropathol 115:509–532. https://doi.org/10.1007/s00401-007-0311-9 · DOI · Paper page
  52. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington’s disease. J Neuropathol Exp Neurol 44:559–577 · DOI · Paper page
  53. White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, MacDonald ME (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington’s disease CAG expansion. Nat Genet 17:404–410. https://doi.org/10.1038/ng1297-404 · DOI · Paper page
  54. Wiestler OD, von Siebenthal K, Schmitt HP, Feiden W, Kleihues P (1989) Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2). Acta Neuropathol 79:137–143. https://doi.org/10.1007/bf00294370 · doi:10.1007/bf00294370

Cited by

Metadata

Authors
Hickman, R. A., Faust, P. L., Rosenblum, M. K., Marder, K., Mehler, M. F., & Vonsattel, J. P.
Venue
Acta Neuropathologica
Published
2021-01-30
Volume
141
Issue
3
Pages
399-413
ISSN
  • 0001-6322
  • 1432-0533
Cited by
42
References
7
Language
en
Licence
Funders
  • Hereditary Disease Foundation
  • Huntington's Disease Society of America

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.